Another interesting placebo-controlled clinical trial, conducted with a 1 g RES dose for 45 days in type 2 DM patients, showed decreased fasting blood glucose, hemoglobin A1c, insulin, and insulin resistance values with a concomitant increase of HDL cholesterol, which are all specific anti-diabetic effects [288]. The gene discussed is INS; the disease is Insulin resistance.